A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15756013

Clin. Cancer Res. 2005 Mar 1 11 5 1877-83

Download in:

View as

Triples

General Info

PMID
15756013